Turk Ilac ve Serum Sanayi AS (TRILC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL44.50 Million ≈ $996.76K USD) by net assets (TL1.91 Billion ≈ $42.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TRILC market cap overview for the company's overall valuation and market capitalisation.

Turk Ilac ve Serum Sanayi AS - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Turk Ilac ve Serum Sanayi AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Turk Ilac ve Serum Sanayi AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their cash flow conversion efficiency. Explore earnings quality score of Turk Ilac ve Serum Sanayi AS to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Kidoz Inc V:KIDZ	0.061x
Filter Vision Public Company Limited BK:FVC	-0.091x
Asuransi Ramayana Tbk JK:ASRM	-0.017x
Reitmans Canada Ltd V:RET	0.172x
Higher Way Electronic Co Ltd TWO:3268	-0.040x
Inalways TWO:5398	0.012x
Pivotree Inc V:PVT	0.002x
Axteria Group Bhd KLSE:7120	-0.024x

Annual Cash Flow Conversion Efficiency for Turk Ilac ve Serum Sanayi AS (2018–2024)

The table below shows the annual cash flow conversion efficiency of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. View Turk Ilac ve Serum Sanayi AS stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL1.92 Billion ≈ $43.09 Million	TL-378.48 Million ≈ $-8.48 Million	-0.197x	-185.55%
2023-12-31	TL1.78 Billion ≈ $39.76 Million	TL408.19 Million ≈ $9.14 Million	0.230x	+1193.03%
2022-12-31	TL564.69 Million ≈ $12.65 Million	TL-11.88 Million ≈ $-266.08K	-0.021x	+90.49%
2021-12-31	TL324.08 Million ≈ $7.26 Million	TL-71.67 Million ≈ $-1.61 Million	-0.221x	-198.67%
2020-12-31	TL148.13 Million ≈ $3.32 Million	TL33.20 Million ≈ $743.59K	0.224x	+9.86%
2019-12-31	TL65.28 Million ≈ $1.46 Million	TL13.32 Million ≈ $298.28K	0.204x	-66.57%
2018-12-31	TL62.47 Million ≈ $1.40 Million	TL38.13 Million ≈ $853.93K	0.610x	--

About Turk Ilac ve Serum Sanayi AS

IS:TRILC Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$21.83 Million

TL974.78 Million TRY

Market Cap Rank

#24927 Global

#417 in Turkey

Share Price

TL0.94

Change (1 day)

-2.08%

52-Week Range

TL0.94 - TL23.34

All Time High

TL37.80